Affimed N.V. AFMD

Quarterly report 2022-Q2
added 08-11-2022

Affimed N.V. DIO Ratio 2011-2026 | AFMD

Annual DIO Ratio Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	69.8	83.2	88.5	69.9	92.3	86.9	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
92.3	69.8	81.8

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	ADMA Biologics ADMA	316	$ 16.45	0.43 %	$ 3.92 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.83	4.23 %	$ 4.53 M	China
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	ANI Pharmaceuticals ANIP	181	$ 76.75	0.85 %	$ 1.48 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	AVEO Pharmaceuticals AVEO	63.8	-	-	$ 521 M	USA
	Axsome Therapeutics AXSM	168	$ 163.82	-0.14 %	$ 8.15 B	USA
	BridgeBio Pharma BBIO	233	$ 66.98	3.8 %	$ 12.8 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BioMarin Pharmaceutical BMRN	644	$ 60.75	3.79 %	$ 11.7 B	USA
	Agenus AGEN	0.163	$ 3.24	1.73 %	$ 1.16 M	USA
	Agios Pharmaceuticals AGIO	1.74 K	$ 28.49	0.04 %	$ 1.65 B	USA
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA